Published in JAMA on September 12, 2007
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation (2010) 3.13
The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr (2012) 1.82
Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J (2012) 1.76
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol (2014) 1.56
Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation (2015) 1.55
Safety of aprotinin in congenital heart operations: results from a large multicenter database. Ann Thorac Surg (2010) 1.48
The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. Pediatr Cardiol (2012) 1.42
Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med (2014) 1.26
Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window. Sci Transl Med (2015) 1.25
Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS One (2010) 1.21
Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol (2013) 1.17
Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results. Acta Myol (2012) 1.14
Pediatric cardiovascular drug trials, lessons learned. J Cardiovasc Pharmacol (2011) 1.13
Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol (2011) 1.12
Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol (2009) 1.11
Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics (2012) 1.05
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol (2015) 0.99
Pediatric Cardiomyopathy as a Chronic Disease: A Perspective on Comprehensive Care Programs. Prog Pediatr Cardiol (2008) 0.97
The importance of randomized controlled trials in pediatric cardiology. JAMA (2007) 0.95
Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy. Circ Heart Fail (2014) 0.95
Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. Am J Cardiol (2009) 0.94
Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br J Clin Pharmacol (2007) 0.94
Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development. Pediatr Cardiol (2011) 0.93
Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol (2011) 0.91
Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2011) 0.88
Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome. J Heart Lung Transplant (2014) 0.87
miRNA expression in pediatric failing human heart. J Mol Cell Cardiol (2013) 0.87
New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group. Circulation (2014) 0.86
A contemporary assessment of the risk for sudden cardiac death in patients with congenital heart disease. Pediatr Cardiol (2012) 0.86
Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am J Physiol Heart Circ Physiol (2013) 0.85
Pediatric heart transplantation-indications and outcomes in the current era. J Thorac Dis (2014) 0.84
Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children. Prog Pediatr Cardiol (2008) 0.82
Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease. Heart Vessels (2009) 0.82
Heart Failure in Pediatric Patients With Congenital Heart Disease. Circ Res (2017) 0.81
Molecular Mechanisms of Right Ventricular Failure. Circulation (2015) 0.79
Echocardiographic evaluation of children with systemic ventricular dysfunction treated with carvedilol. Pediatr Cardiol (2010) 0.79
Clinical practice: heart failure in children. Part II: current maintenance therapy and new therapeutic approaches. Eur J Pediatr (2010) 0.79
MicroRNAs in right ventricular (dys)function (2013 Grover Conference series). Pulm Circ (2014) 0.79
Myocardial perfusion abnormalities in patients occurring more than 1 year after successful univentricular (Fontan surgery) and biventricular repair (complete repair of tetralogy of Fallot). Pediatr Cardiol (2012) 0.79
Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients. Pediatr Cardiol (2015) 0.78
"Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr (2016) 0.78
Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth. PLoS One (2016) 0.78
Epidemiology and cost of heart failure in children. Cardiol Young (2015) 0.78
Anti-hypertensive drugs in children and adolescents. World J Cardiol (2014) 0.78
Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy. Med Sci Monit (2013) 0.78
Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy. Pediatr Res (2014) 0.78
Pediatric heart failure: current state and future possibilities. Korean Circ J (2015) 0.78
Validation of Noninvasive Measures of Left Ventricular Mechanics in Children: A Simultaneous Echocardiographic and Conductance Catheterization Study. J Am Soc Echocardiogr (2016) 0.77
The Right Heart in Congenital Heart Disease, Mechanisms and Recent Advances. J Clin Exp Cardiolog (2012) 0.77
β-Adrenergic receptor antagonism in mice: a model for pediatric heart disease. J Appl Physiol (1985) (2013) 0.77
The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant (2011) 0.77
Myocardial Response to Milrinone in Single Right Ventricle Heart Disease. J Pediatr (2016) 0.76
Molecular Changes in Children with Heart Failure Undergoing Left Ventricular Assist Device Therapy. J Pediatr (2016) 0.76
Cardiac regeneration in children. Pediatr Cardiol (2015) 0.76
Clinical Characteristics and Treatment of Cardiomyopathies in Children. Curr Cardiol Rev (2016) 0.75
Role of β-blocker therapy in pediatric heart failure. Ped Health (2010) 0.75
Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J (2011) 0.75
A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials. BMC Pediatr (2009) 0.75
Massive Cardiomegaly due to Dilated Cardiomyopathy Causing Bronchial Obstruction in an Infant. J Cardiovasc Ultrasound (2014) 0.75
Heart Failure in Children. Heart Views (2016) 0.75
Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment. J Card Fail (2016) 0.75
Duchenne muscular dystrophy: the management of scoliosis. J Spine Surg (2016) 0.75
Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion. Ann Pediatr Cardiol (2009) 0.75
Protective Effects of Carvedilol and Vitamin C against Azithromycin-Induced Cardiotoxicity in Rats via Decreasing ROS, IL1-β, and TNF-α Production and Inhibiting NF-κB and Caspase-3 Expression. Oxid Med Cell Longev (2016) 0.75
Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation. Circulation (2014) 0.75
Respiratory Failure in an Adolescent with Primary Cardiac Sarcoma. Case Rep Cardiol (2015) 0.75
Pharmacologic Approach to Heart Failure in Children. Curr Cardiol Rev (2016) 0.75
Long term negative pressure ventilation: Rescue for the failing fontan? World J Cardiol (2014) 0.75
Carvedilol of no clear benefit for systolic heart failure in children. J Pediatr (2008) 0.75
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure. BMC Cardiovasc Disord (2016) 0.75
Clinical cardiac regenerative studies in children. World J Cardiol (2017) 0.75
Cardiomyopathies: Treating pediatric DCM--great expectations unfulfilled. Nat Rev Cardiol (2010) 0.75
Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database. Cardiol Young (2015) 0.75
Successful treatment of arrhythmia-induced cardiomyopathy in an infant with tuberous sclerosis complex. BMC Pediatr (2016) 0.75
The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand. Pediatr Cardiol (2016) 0.75
Medical Therapy Leads to Favorable Remodeling in Left Ventricular Non-compaction Cardiomyopathy: Dilated Phenotype. Pediatr Cardiol (2016) 0.75
Outcomes in Patients with Persistent Ventricular Dysfunction After Stage I Palliation for Hypoplastic Left Heart Syndrome. Pediatr Cardiol (2015) 0.75
The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy. Clin Res Cardiol (2014) 0.75
Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease. PLoS One (2017) 0.75
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil. Circ Cardiovasc Qual Outcomes (2017) 0.75
The Total Artificial Heart in End-Stage Congenital Heart Disease. Front Physiol (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet (2009) 7.23
A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med (2007) 6.50
Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med (2010) 5.43
Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med (2014) 5.11
Therapeutic hypothermia after out-of-hospital cardiac arrest in children. N Engl J Med (2015) 4.90
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation (2008) 3.63
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA (2004) 3.20
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation (2010) 3.13
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol (2008) 2.91
Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol (2004) 2.86
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet (2013) 2.82
Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics (2004) 2.66
Baseline serum concentrations of zinc, selenium, and prolactin in critically ill children. Pediatr Crit Care Med (2013) 2.66
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant (2007) 2.55
Risk factors for pediatric arachnoid cyst rupture/hemorrhage: a case-control study. Neurosurgery (2013) 2.51
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol (2003) 2.47
Functional Status Scale: new pediatric outcome measure. Pediatrics (2009) 2.42
Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr (2014) 2.27
Simultaneous Prediction of New Morbidity, Mortality, and Survival Without New Morbidity From Pediatric Intensive Care: A New Paradigm for Outcomes Assessment. Crit Care Med (2015) 2.24
Nonvalvular cardiovascular device-related infections. Circulation (2003) 2.19
Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J (2007) 2.14
Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg (2008) 2.12
Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol (2012) 2.10
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07
Spontaneous regression of left ventricular dilation in children with restrictive ventricular septal defects. J Pediatr (2007) 2.05
Outcome and resource utilization of infants born with hypoplastic left heart syndrome in the Intermountain West. Am J Cardiol (2012) 2.04
Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant (2011) 2.03
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant (2007) 2.03
The Pediatric Risk of Mortality Score: Update 2015. Pediatr Crit Care Med (2016) 1.96
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
The ideal time interval for critical care severity-of-illness assessment. Pediatr Crit Care Med (2013) 1.91
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics (2012) 1.91
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol (2004) 1.89
Pediatric intensive care outcomes: development of new morbidities during pediatric critical care. Pediatr Crit Care Med (2014) 1.84
The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr (2012) 1.82
Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol (2004) 1.80
The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med (2012) 1.79
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation (2003) 1.78
Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation (2006) 1.78
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. J Heart Lung Transplant (2006) 1.78
Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation (2003) 1.77
Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med (2013) 1.74
Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J (2006) 1.74
BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail (2010) 1.73
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report--2005. J Heart Lung Transplant (2005) 1.70
Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). Eur J Cardiothorac Surg (2005) 1.68
Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation (2005) 1.67
Transnasal endoscopy vs. fluoroscopy for the placement of nasoenteric feeding tubes in critically ill patients. Gastrointest Endosc (2005) 1.65
Ratio of PICU versus ward cardiopulmonary resuscitation events is increasing. Crit Care Med (2013) 1.65
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation (2007) 1.64
Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2008) 1.63
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J (2003) 1.61
Body weight changes with beta-blocker use: results from GEMINI. Am J Med (2007) 1.60
International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant (2004) 1.59
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. J Heart Lung Transplant (2006) 1.58
Effective pain reduction for multiple immunization injections in young infants. Arch Pediatr Adolesc Med (2003) 1.58
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol (2007) 1.58
Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr (2009) 1.58
Children with cardiomyopathy: complications after noncardiac procedures with general anesthesia. Paediatr Anaesth (2007) 1.55
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. Hypertension (2005) 1.54
Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med (2012) 1.53
Expected changes in clinical measures of adiposity during puberty. J Adolesc Health (2010) 1.53
Opioid analgesia in mechanically ventilated children: results from the multicenter Measuring Opioid Tolerance Induced by Fentanyl study. Pediatr Crit Care Med (2013) 1.53
Fatal and near-fatal asthma in children: the critical care perspective. J Pediatr (2012) 1.51
The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol (2010) 1.51
Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. J Am Coll Cardiol (2005) 1.48
Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab (2003) 1.47
Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.46
Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr (2007) 1.46
Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study. J Clin Hypertens (Greenwich) (2010) 1.46
Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study. Pediatr Transplant (2011) 1.45
Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients? Pediatr Transplant (2013) 1.44
Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data. Epidemiology (2006) 1.44
Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant (2010) 1.43
Use of a virtual community as a psychosocial support system in pediatric transplantation. Pediatr Transplant (2010) 1.43
Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant (2009) 1.42
Rheumatic fever presenting as monoarticular arthritis. Pediatr Infect Dis J (2006) 1.42